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CEFTRIAXONE-RESISTANT SALMONELLA INFECTION ACQUIRED BY A CHILD
FROM CATTLE
PAUL D. FEY, PH.D., THOMAS J. SAFRANEK, M.D., MARK E. RUPP, M.D., EILEEN F. DUNNE, M.D., M.P.H.,
EFRAIN RIBOT, PH.D., PETER C. IWEN, M.S., PATRICIA A. BRADFORD, PH.D., FREDERICK J. ANGULO, D.V.M., PH.D.,
AND STEVEN H. HINRICHS, M.D.

ABSTRACT
Background The emergence of resistance to antimicrobial agents within the salmonellae is a worldwide problem that has been associated with the use
of antibiotics in livestock. Resistance to ceftriaxone
and the fluoroquinolones, which are used to treat invasive salmonella infections, is rare in the United
States. We analyzed the molecular characteristics of
a ceftriaxone-resistant strain of Salmonella enterica
serotype typhimurium isolated from a 12-year-old boy
with fever, abdominal pain, and diarrhea.
Methods We used pulsed-field gel electrophoresis
and analysis of plasmids and b -lactamases to compare the ceftriaxone-resistant S. enterica serotype typhimurium from the child with four isolates of this
strain obtained from cattle during a local outbreak of
salmonellosis.
Results The ceftriaxone-resistant isolate from the
child was indistinguishable from one of the isolates
from cattle, which was also resistant to ceftriaxone.
Both ceftriaxone-resistant isolates were resistant to
13 antimicrobial agents; all but one of the resistance
determinants were on a conjugative plasmid of 160
kb that encoded the functional group 1 b -lactamase
CMY-2. Both ceftriaxone-resistant isolates were closely related to the three other salmonella isolates obtained from cattle, all of which were susceptible to
ceftriaxone.
Conclusions This study provides additional evidence that antibiotic-resistant strains of salmonella
in the United States evolve primarily in livestock. Resistance to ceftriaxone, the drug of choice for invasive salmonella disease, is a public health concern,
especially with respect to children, since fluoroquinolones, which can also be used to treat this disease,
are not approved for use in children. (N Engl J Med
2000;342:1242-9.)
©2000, Massachusetts Medical Society.

O

F the estimated 1.4 million salmonella infections that occur each year in the United
States, most are in children and the elderly and approximately 600 are fatal.1 Septicemia complicates at least 7 percent of the 40,000
culture-confirmed infections that are reported each
year.1,2 Although antibiotics are not essential for the
treatment of most cases of salmonellosis, they can be
lifesaving in persons with invasive disease. Expandedspectrum cephalosporins (e.g., ceftriaxone) are commonly used to treat salmonella infections in children
because of their pharmacodynamic properties and
1242 ·
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the very low prevalence of resistance to these agents.
Since 1991, salmonella species that are resistant to
expanded-spectrum cephalosporins have been reported in several countries, including Argentina, Turkey,
Algeria, Saudi Arabia, Greece, Tunisia, and France.3-12
In these isolates, a variety of b-lactamases from functional groups 1 and 2 have been described.13 However, only three ceftriaxone-resistant infections have
been reported in the United States, and each was associated with international travel.14 These 3 isolates
were detected in 1995 in a national survey of more
than 4000 isolates.14 Ceftriaxone-resistant salmonella have been reported very rarely by national surveillance systems in the United Kingdom and Denmark,
further demonstrating the low prevalence of ceftriaxone-resistant salmonella worldwide15 (and Threlfall EJ: personal communication).
Epidemiologic investigations have demonstrated
that in the United States, the use of antimicrobial
agents in livestock is the principal cause of the emergence and dissemination of resistance to antimicrobial agents in strains of nontyphoidal salmonella.16-18
However, few investigations have been successful in
tracing antibiotic-resistant infections in humans to a
source on a farm. We used molecular methods to establish a connection between a domestically acquired
ceftriaxone-resistant salmonella infection in a child
and related isolates from cattle.
CASE REPORT
In April 1998, a 12-year-old boy living in western Nebraska
had acute abdominal pain with fever. The boy had been well with
the exception of a sinus infection treated with amoxicillin–clavulanate. He had finished his 10-day course of treatment 4 days before the onset of abdominal pain. He began a prophylactic regimen
of ampicillin–sulbactam and underwent an appendectomy. Histologic examination of the appendix showed acute mucosal inflammation but no involvement of the serosa or muscularis. Two
days after surgery, treatment with ampicillin–sulbactam was discontinued and treatment with amoxicillin–clavulanate was begun.
The following day the patient began to have diarrhea, and a stool
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culture yielded Salmonella enterica serotype typhimurium. The
patient was discharged and had an uneventful recovery.
The isolate was analyzed at the Nebraska Public Health Laboratory and found to be resistant to ampicillin, chloramphenicol,
tetracycline, sulfisoxazole, kanamycin, and streptomycin as well as
to broad-spectrum cephalosporins (e.g., cephalothin) and expanded-spectrum cephalosporins (e.g., ceftriaxone, which is used in
humans, and ceftiofur, which is used in animals), aztreonam, cefoxitin, gentamicin, and tobramycin. Further investigation was conducted by epidemiologists at the Nebraska Department of Health
and Human Services and the Centers for Disease Control and
Prevention (CDC). In March 1998, the patient’s father had treated calves with a severe diarrheal disorder from his own herd and
three other herds. Several of the calves had died. Stool specimens
from ill cattle in each herd were analyzed at the University of
Nebraska Panhandle Research and Extension Center and yielded
S. enterica serotype typhimurium. During the two-week period
before his illness, the boy had not accompanied his father on visits
to other herds and had not traveled outside the United States.
Reports of the boy’s illness prompted an investigation by public
health officials. No additional ceftriaxone-resistant salmonella infections were reported in Nebraska or adjoining states.

METHODS
Bacterial Strains and Antibiotic Susceptibility
Five isolates of S. enterica serotype typhimurium were studied:
the one from the boy and four from cattle (one from each herd
associated with the outbreak of salmonellosis). The susceptibility
of these isolates to antimicrobial agents was determined by the
broth-microdilution or disk-diffusion method in accordance with
the standards of the National Committee for Clinical Laboratory
Standards19,20 and with the E test, according to the manufacturer’s recommendations (AB Biodisk, Solona, Sweden). The double
disk-diffusion assay was used to screen for the presence of extended-spectrum b-lactamases according to published methods.21 Isolates were serotyped and phage typed at the CDC with the use
of standard methods.22
Pulsed-Field Gel Electrophoresis and Plasmid Analysis
Genomic DNA suitable for pulsed-field gel electrophoresis
(PFGE) was prepared according to published methods and digested with the restriction endonuclease XbaI (Roche, Indianapolis).23
Three salmonella isolates, including a strain of S. enterica serotype
typhimurium known as definitive phage type 104 (DT104), from
ill persons in Nebraska were used for comparison. Plasmids encoded by Escherichia coli V517, 24 R1, 25 and PDK9 (CDC strain
collection) were used as size standards. Plasmid DNA from all
strains studied was isolated with the use of either a kit (Qiagen
midi-preps, Qiagen, Valencia, Calif.) or a modified alkaline lysis
procedure.26
Transconjugation Studies
The isolate from the child, one of the cattle isolates (cattle isolate 1), and the DT104 isolate (which is resistant to ampicillin and
susceptible to nalidixic acid) were transconjugated with E. coli
C600N, 27 which is resistant to nalidixic acid and susceptible to
ampicillin, with the use of standard methods. 28 DT104 was transconjugated with C600N to serve as a negative control. 29
Isoelectric Focusing
Isoelectric focusing was performed according to the method of
Mathew et al.30 at 10°C (Multiphor apparatus, Pharmacia LKB,
Uppsala, Sweden) with prepared polyacrylamide-gel plates (pH
range, 3.5 to 9.5) (Pharmacia). TEM-1, TEM-2, K1, SHV-1, and
P99 b-lactamases were used as standards.
Amplification, Sequencing, and Hybridization
The polymerase-chain-reaction (PCR) primers that were used to
identify the ampC gene of Citrobacter freundii and TEM-related

sequences have been described previously.28,31 The sequence of
both strands was analyzed. Southern hybridization was performed
according to standard methods32 with DNA probes labeled with
digoxigenin-11-deoxyuridine triphosphate (Roche).

RESULTS
Susceptibility to Antibiotics, Serotype, and Phage Type
of the Isolates

The isolate from the child and the four isolates
from cattle were serotyped at the CDC and found to
be S. enterica serotype typhimurium variant Copenhagen. All five isolates had the same pattern of phage
lysis, which did not match previously described type
designations. Susceptibility testing revealed that the
isolate from the child and cattle isolate 1 had an identical pattern, including resistance to ceftriaxone (minimal inhibitory concentration, »64 µg of ceftriaxone per milliliter) and ceftiofur (minimal inhibitory
concentration, »16 µg of ceftiofur per milliliter). Although not resistant to ceftriaxone or ceftiofur, the
other three isolates from cattle were resistant to five
antimicrobial agents (ampicillin, tetracycline, kanamycin, streptomycin, and sulfisoxazole). Double diskdiffusion testing showed that the b-lactamase that
conferred resistance to ceftriaxone and other expanded-spectrum cephalosporins was not inhibited by the
b-lactamase inhibitor clavulanate and was therefore
not phenotypically classified as an extended-spectrum
b-lactamase (functional group 2be).13
PFGE

PFGE was used to determine the molecular relatedness of the isolate from the child and the four cattle
isolates (Fig. 1). All five isolates had similar restriction-fragment patterns; however, they had a number
of bands that differed from those of S. enterica serotype typhimurium DT104 and two non-DT104
control strains of S. enterica serotype typhimurium
(REF42 and REF65) that were isolated in Nebraska.
The isolate from the child and cattle isolate 1, the
two ceftriaxone-resistant isolates, were closely related
except for differences in bands K and P (Fig. 1). Both
ceftriaxone-resistant isolates also contained a 160-kb
band (band I) as well as a slightly larger band (band
H) that the ceftriaxone-susceptible isolates from cattle did not have. Cattle isolates 2 and 4 were identical, whereas cattle isolate 3, although very similar to
cattle isolates 2 and 4, differed with respect to band
K. Cattle isolate 1 was very similar to cattle isolates
2 and 4, except with respect to bands I and H. The
isolate from the child appeared to have the same
band K as cattle isolate 3. The origin of these differences was subsequently determined.
Transconjugation Experiments and Analysis of Plasmids

To determine whether ceftriaxone and other antibiotic-resistance factors of the isolate from the child
and cattle isolate 1 were mediated by plasmids, both
strains were transconjugated with E. coli C600N. The
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Figure 1. Results of Pulsed-Field Gel Electrophoresis of Isolates of Salmonella enterica Serotype Typhimurium from a 12-Year-Old Boy and Cattle.
Lanes 1 and 2 show control strains of S. enterica serotype typhimurium (REF42 and REF65, respectively), lanes 3 and 4 S. enterica serotype typhimurium definitive phage type 104 (DT104), lane 5 the isolate
from the child, lane 6 cattle isolate 2, lane 7 cattle isolate 3, lane 8 cattle isolate 4, and lane 9 cattle
isolate 1. The isolate from the child includes a unique band, labeled P. Bands H and I were found in
both the isolate from the child and cattle isolate 1. There were additional differences among the isolates with respect to band K. Bands I, K, and P were all found to be of plasmid origin.

transconjugants exhibited decreased susceptibility to
all antimicrobial agents (including ceftriaxone, ceftiofur, and cefoxitin) to which the isolate from the
child and cattle isolate 1 were resistant, except kanamycin (data not shown). The results of PFGE used
to confirm the E. coli C600N lineage showed an additional XbaI band in each ceftriaxone-resistant transconjugant. This new band was the same size as band
I in both ceftriaxone-resistant salmonella isolates, suggesting that this band carried the genetic material
mediating resistance to ceftriaxone.
1244 ·
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The isolates from the child and the cattle were analyzed for plasmids. The two ceftriaxone-resistant isolates (lanes 1 and 2 in Fig. 2A) both had plasmid
bands of 160 kb. The isolate from the child contained
two additional plasmids, one of 55 kb and one of
125 kb. The band of 125 kb was also present in cattle
isolates 2 and 3 (lanes 3 and 4, respectively, in Fig. 2A)
and cattle isolate 4 (data not shown). Plasmid bands
of 140 kb were seen in cattle isolates 1 and 2 (Fig. 2A).
The plasmid profiles of cattle isolates 2 and 4 were
indistinguishable (data not shown).
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Figure 2. Plasmid Analysis of Isolates of Salmonella enterica Serotype Typhimurium and of Transconjugants.
The results for cattle isolate 4 are not shown. Panel A shows the 160-kb plasmid that was found in the isolate from the
child (lane 1) and cattle isolate 1 (lane 2); the 140-kb plasmid that was found in cattle isolates 1, 2 (lane 3), and 4; the
125-kb plasmid that was found in the isolate from the child and cattle isolates 2, 3 (lane 4), and 4; and the 55-kb plasmid
that was found only in the isolate from the child. Panel B shows the plasmids found in ceftriaxone-resistant transconjugants of Escherichia coli C600N and S. enterica serotype typhimurium. The 160-kb conjugative plasmid found only in
the ceftriaxone-resistant cattle isolate 1 (lane 1) and the isolate from the child (lane 2) was transferred by transconjugation of these isolates with E. coli C600N (lanes 3 and 4, respectively). The 55-kb plasmid in the isolate from the child
was not transferred.

The plasmid profiles of the salmonella isolates and
the E. coli C600N transconjugants resulting from
transconjugation with the isolate from the child and
cattle isolate 1 were compared. The ceftriaxone-resistant transconjugants both contained the band of 160
kb that was found in cattle isolate 1 and the isolate
from the child (Fig. 2B), but not the bands of 55 kb
and 125 kb that were found in the isolate from the
child or the 140-kb band that was found in cattle
isolate 1.
b-Lactamase Analysis

Isoelectric focusing was performed to characterize
the b-lactamases present in the five salmonella isolates and the ceftriaxone-resistant transconjugants.
Cattle isolates 2, 3, and 4 all expressed one b-lactamase with an isoelectric point of 5.4. This finding,
in conjunction with their antibiotic-resistance profile,
suggested that these isolates produced a TEM-1–
like b-lactamase. The isolate from the child and cattle
isolate 1 produced not only the TEM-1–like b-lactamase but also one with an isoelectric point of at
least 9.0, suggestive of an AmpC-like enzyme. Moreover, all four ceftriaxone-resistant transconjugants contained the AmpC-like b-lactamase (isoelectric point,

»9.0), further suggesting that this b-lactamase was
responsible for the ceftriaxone resistance and that it
was encoded on the conjugative plasmid of approximately 160 kb. The TEM-1–like b-lactamase was not
present in the transconjugants.
Specific primers for the ampC gene of C. freundii
were used to characterize the AmpC-like b-lactamase found in the isolate from the child, cattle isolate 1, and their transconjugants. This analysis yielded a PCR product of the expected size (631 bp)
from the isolate from the child, cattle isolate 1, and
their transconjugants. Cattle isolates 2, 3, and 4 were
negative on PCR testing for the 631-bp amplicon.
These findings indicated that a b-lactamase (isoelectric point, »9.0) closely related to the ampC gene
of C. freundii was responsible for the ceftriaxone resistance of these isolates.
To characterize the b-lactamase with an isoelectric
point of 5.4 that was present in all the salmonella
isolates, primers specific for the TEM family of b-lactamases were used. All isolates were positive, but the
transconjugants were negative. This finding demonstrated that the TEM-1–like b-lactamase was not encoded on the same plasmid as the AmpC-like b-lactamase.
Vol ume 342
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To prove that the AmpC-like b-lactamase was encoded on the 160-kb plasmid that was found only in
the isolate of the child, cattle isolate 1, and their
transconjugants, C. freundii ampC-like PCR products were labeled and used as probes. Southern blot
analysis of a PFGE gel (Fig. 3) demonstrated that the
AmpC-like b-lactamase probe hybridized to band I,
which was found only in the ceftriaxone-resistant isolate from the child, cattle isolate 1, and their transconjugants. Since transconjugation studies had shown
that the AmpC-like b-lactamase was derived from a
plasmid, we concluded that the additional band I was
the unique 160-kb plasmid that was found in the
ceftriaxone-resistant isolates.
Southern blot analysis demonstrated that the
TEM-1 b-lactamase was encoded on the plasmids in
all clinical isolates and not on the chromosome (data
not shown). This analysis demonstrated that TEM-1
was encoded on the 125-kb plasmid in the isolate
from the child and cattle isolate 3 and on the 140-kb
plasmid in cattle isolates 1, 2, and 4, raising the possibility that band K was derived from a plasmid. To
answer this question, we hybridized DNA, which had
been separated by PFGE, with a TEM-1 probe (Fig.
4). These results demonstrated that band K was derived from a plasmid and represented the 125-kb
plasmid found in both the isolate from the child and
cattle isolate 3 and the 140-kb plasmid found in cattle isolates 1, 2, and 4.
To determine whether the 55-kb plasmid that was
found in the isolate from the child represented band
P identified on PFGE analysis, plasmid DNA and
chromosomal DNA digested with XbaI were electrophoresed on the same gel. The analysis showed that
band P was the same size as the plasmid.
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DNA Sequencing

The AmpC-like b-lactamase from the ceftriaxoneresistant transconjugant of E. coli C600N and the
isolate from the child was completely sequenced and
found to be 100 percent homologous to the plasmidic cephamycinase CMY-2.33
DISCUSSION

On the basis of reports sent to the CDC, we believe that this case represents the first documented
domestically acquired ceftriaxone-resistant salmonella infection in the United States. Although the means
of transmission is not known, the child apparently
acquired the illness from cattle. Several lines of evidence, in addition to the epidemiologic findings, support the hypothesis that the child’s gastrointestinal
infection was acquired from cattle on his family’s
ranch or nearby ranches that had had outbreaks of
salmonellosis among cattle. First, the isolate from the
child and all the cattle isolates were S. enterica serotype typhimurium variant Copenhagen and had the
same distinct pattern of phage lysis. Second, the iso1246 ·
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Figure 3. Results of Pulsed-Field Gel Electrophoresis of Isolates
of Salmonella enterica Serotype Typhimurium from a 12-YearOld Boy and Cattle and of Transconjugants.
In each panel, lane 1 shows cattle isolate 2, lane 2 the isolate
from the child, and lanes 3 and 4 ceftriaxone-resistant transconjugant of Escherichia coli C600N with the isolate from the child
and cattle isolate 1, respectively. In Panel A, band I was found
only in the ceftriaxone-resistant isolates and their ceftriaxoneresistant transconjugants. In Panel B, Southern blot analysis
with cmy-2 PCR product as the probe indicates that band I is of
plasmid origin and corresponds to the 160-kb plasmid shown
in Figure 2. There is no hybridization in ceftriaxone-susceptible
cattle isolate 2.
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Figure 4. Results of Pulsed-Field Gel Electrophoresis of Isolates
of Salmonella enterica Serotype Typhimurium from a 12-YearOld Boy and Cattle and of Transconjugants.
In each panel, lane 1 shows cattle isolate 2, lane 2 cattle isolate
1, lane 3 isolate from the child, lane 4 the ceftriaxone-resistant
transconjugant of Escherichia coli C600N and the isolate from
the child, and lane 5 the ceftriaxone-resistant transconjugant of
E. coli C600N and cattle isolate 1. Panel A shows band K, and
Panel B shows the results of Southern blot hybridization with a
952-bp TEM-1 PCR product amplified from the isolate from the
child. The results indicate that band K is of plasmid origin and encodes TEM-1 b-lactamase. The additional bands in lanes 1 and
2 of Panel B may indicate nicked or supercoiled forms of the
plasmids that encode TEM-1. There was no hybridization of the
TEM-1 probe in the ceftriaxone-resistant transconjugants (lanes
4 and 5).

late from the child and one of the cattle isolates (cattle
isolate 1) had the same, extremely rare pattern of resistance to antibiotics. Finally, the presence of plasmid
DNA could account for almost all the differences in
bands among the isolates that were found on PFGE.
These differences between cattle isolate 1 and the iso-

late from the child were in two bands (K and P) subsequently shown to be of plasmid origin. Therefore,
the isolate from the child and cattle isolate 1 can be
considered to be the same strain. One additional band
(I), unique to the ceftriaxone-resistant isolates, was
also shown to be of plasmid origin and encoded a
CMY-2 b-lactamase as well as other antibiotic-resistance genes. The only genomic differences among the
isolate from the child, cattle isolate 1, and the ceftriaxone-susceptible cattle isolates lay in the larger size
of band H in both cattle isolate 1 and the isolate
from the child. According to the criteria of Tenover
et al. for analysis of banding patterns on PFGE, all
the isolates were highly related.34
Although antimicrobial therapy is not essential for
the treatment of most salmonella infections, such
therapy may be lifesaving in persons with invasive
disease. Expanded-spectrum cephalosporins, especially ceftriaxone, are frequently used empirically to treat
salmonella infections in children. The identification
of a domestically acquired CMY-2–mediated ceftriaxone-resistant salmonella infection and its apparent
circulation in cattle suggest that such infections could
become more common in the United States, especially since the resistance to ceftriaxone is mediated
by a plasmid. There are few alternative antimicrobial
agents for the empirical treatment of salmonella infections in children, since fluoroquinolones have not
been approved for use in children.
Our findings add to the accumulating body of
evidence suggesting that the use of antimicrobial
agents in livestock is the dominant source of resistance to these agents in salmonella. Previous studies
have shown that salmonella isolates from both humans
and animals share antibiotic-resistance plasmids.35 Although no information was available regarding the use
of antimicrobial agents among the four infected herds
on the patient’s ranch and neighboring ranches, the
results of PFGE suggest that the ceftriaxone-resistant
strain of S. enterica serotype typhimurium variant
Copenhagen that infected the child was present in at
least one herd. In addition, the ceftriaxone-resistant
isolate from cattle (cattle isolate 1) was closely related
to other, possibly endemic, ceftriaxone-susceptible
isolates of S. enterica serotype typhimurium variant
Copenhagen that were obtained during the same outbreak of salmonellosis (cattle isolates 2, 3, and 4).
It is probable that the use of antimicrobial agents
in cattle led to the selection of the ceftriaxone-resistant strain that was subsequently transmitted to the
child. Although we were unable to establish its use
in these herds, an expanded-spectrum cephalosporin
(ceftiofur) is approved for use and is widely used in
domestic animals, including cattle. Other factors besides cephalosporin use (e.g., the use of other antibiotics or unknown environmental factors) could have
selected for and maintained this plasmid within the
bacterial population in the involved herds. Although
Vol ume 342
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the means of transmission of the ceftriaxone-resistant salmonella from the cattle to the child is not
known, it is unlikely that the child acquired the infection through food. Therefore, even if salmonella
is eliminated from food, the circulation of highly resistant strains in livestock constitutes a potential public health threat, especially to farmers, ranchers, and
animal handlers.
The inoculum of salmonella necessary to cause illness in this child may have been lowered by the prior
treatment with amoxicillin–clavulanate and ampicillin–sulbactam. The use of antibiotics during or before exposure has frequently been shown to predispose persons to salmonella infections.16,36 Our findings
illustrate the need to use antimicrobial agents prudently both in domestic animals and in humans. The
implementation of appropriate safeguards, including
restricting the use of certain antimicrobial agents in
livestock, may slow the evolution of antimicrobial
resistance in salmonella and prevent the transmission
of resistant strains of salmonella from livestock to
humans.
Our findings demonstrate the ability of nationwide
monitoring programs to detect new antibiotic-resistant strains of bacteria before they become widely disseminated. Continued surveillance for antibiotic-resistant salmonella in livestock and humans is necessary,
particularly to monitor the incidence of ceftriaxoneresistant strains. In this respect, testing for CMY-2–
mediated resistance will be useful to identify the spread
of related strains or plasmids in the United States.
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